Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain.

Neuron | 2016

We recently reported that homozygous Presenilin-1 (Psen1) knockin (KI) mice carrying the familial Alzheimer's disease (FAD) mutation L435F or C410Y recapitulate the phenotypes of Psen1(-/-) mice. Production and steady-state levels of Aβ40 and Aβ42 are undetectable in KI/KI brains and reduced in KI/+ brains, though the Aβ42/Aβ40 ratio is slightly increased in KI/+ brains. Moreover, the FAD mutation impairs synaptic function, learning and memory, and age-dependent neuronal survival in the adult brain. Here we extend our analysis of the effects of the L435F and C410Y mutations to the generation of Aβ43. Similar to Aβ40 and Aβ42, production of Aβ43 is undetectable in KI/KI brains and reduced in KI/+ brains. These results support our previous conclusions that the L435F and C410Y mutations cause loss of Presenilin function and γ-secretase activity, including impaired Aβ production in the brain. This Matters Arising Response paper addresses the Veugelen et al. (2016) Matters Arising paper, published concurrently in Neuron.

Pubmed ID: 27100200 RIS Download

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS075346
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS042818
  • Agency: NINDS NIH HHS, United States
    Id: RF1 NS041783
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS041783
  • Agency: NINDS NIH HHS, United States
    Id: K24 NS093185

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Human Amyloid β (1-43) (FL) Assay Kit (antibody)

RRID:AB_2571514

This unknown targets Amyloid β, Amyloid beta, A-beta, Aβ

View all literature mentions

Human Amyloid β (1-43) (FL) Assay Kit (antibody)

RRID:AB_2571514

This unknown targets Amyloid β, Amyloid beta, A-beta, Aβ

View all literature mentions

Human Amyloid β (1-43) (FL) Assay Kit (antibody)

RRID:AB_2571514

This unknown targets Amyloid β, Amyloid beta, A-beta, Aβ

View all literature mentions

Human Amyloid β (1-43) (FL) Assay Kit (antibody)

RRID:AB_2571514

This unknown targets Amyloid β, Amyloid beta, A-beta, Aβ

View all literature mentions

Human Amyloid β (1-43) (FL) Assay Kit (antibody)

RRID:AB_2571514

This unknown targets Amyloid β, Amyloid beta, A-beta, Aβ

View all literature mentions